No difference in clinical outcomes using follitropin alfa (biosimilar) compared to follitropin alfa or follitropin beta for controlled ovarian stimulation (COS) in oocyte donation-recipient cycles
- 1 September 2018
- journal article
- abstracts
- Published by Elsevier in Fertility and Sterility
- Vol. 110 (4) , e336-E336